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SUMMARY 
Female sex steroid estrogen is the fundamental regulator of normal breast development. In addition 
to this, clinical data showed that aromatase inhibitors reduces early distant metastasis and 
improves disease-free survival  indicating that estrogen may facilitate the progression of breast 
cancer. Cell migration is required for cancer spread, invasion, and metastasis.  Cell migration 
requires the integration of events that induce changes in cell structure such as protrusion, 
polarization and traction toward the direction of migration. These actions are driven by actin 
remodeling. These events are dependent on the rapid activation of FAK and Moesin, a member of 
ERM (Ezrin, Radixin and Moesin) family. However, the mechanistic basis of estrogens on 
endothelial and breast tumor cell motility or invasion remains unclear. The main focus of this 
thesis is to study the role of conventional and unconventional estrogen receptors in cell movement 
in different cell settings. First we used human umbilical vein endothelial cells and ER negative 
MDA MB468 cells to study the mechanistic basis of cell movement in non cancerous human vein 
endothelial cells and breast cancer MDA-MB 468 cells, these two cells enable us to provide 
insights into how steroids induces metastasis in breast cancer cells.  The first part of my thesis 
focuses on exploring the regulatory actions of estrogen on PAI-1 in human endothelial cells and to 
characterize the signaling steps through which these actions are enacted.  Here we have shown that 
estrogen through various signaling intermediates from  membrane to nucleus, to induce the 
expression of PAI-1. Our lab have shown previously that estrogen is the powerful modulator of 
cell movement in ER positive T47D breast cancer cells. The interesting point is that, PAI-1 besides 
being important player in fibrinolysis, also demonstrated to have other roles such as actin 
remodeling. Actin remodeling is the crucial event. The fundamental goal of this second part of 
Thesis are to explore the dynamics and  regulatory controls of actin based processes in an effort to 
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further understand the molecular events governing invasion and cell movement. Within this 
context, the work presented  here focuses on the role of unconventional estrogen  receptors such as 
G-Protein Coupled Estrogen Receptor (GPER) in ER negative breast tumor MDA MB468 cell 
line. Previous studies have shown with debate that, apart from endogenous ER receptors, GPER is 
an unconventional estrogen receptor which is used by sex steroids such as estrogen. Previous 
studies have also shown that estrogen exerts trace effect in the cells without ER, so we 
hypothesized that, this trace effect could be the presence of unconventional GPER in ER negative 
breast cancer cells.  These findings described in this thesis provide new mechanisms of action of 
estrogens through conventional and unconventional estrogen receptors to the actin cytoskeleton 
and cell movement, which may be important for vascular function and heamostasis in endothelial 
cells and invasion and metastasis in breast cancer cells.  
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INTRODUCTION 
Estrogens belongs to steroid hormones that primarily influences the female reproductive tract in its 
development, maturation and function. Apart from the role of steroid hormones in reproductive 
system, it also controls metabolism, inflammation, electrolyte balance and ability to withstand 
illness and injury (Keith L. Parker et al., 2002).Steroid hormones can acts as a chemical messenger 
in a wide range of species and target tissues to produce genomic and non-genomic (rapid) 
responses (Anthony W Norman et al., 2004). Genomic responses to steroid hormones are mediated 
by the formation of a complex hormone and its endogenous receptor termed as steroid hormone 
nuclear receptor while rapid non genomic mediated responses are mediated by the various receptor 
types associated with plasma membrane including membrane-associated nuclear receptor.  
Steroid hormone receptor (SHR) 
The biological effects of steroid hormones are mediated by intracellular receptors that directly 
mediate the action of their cognate hormone. Steroid hormone receptors belong to nuclear receptor 
superfamily, a class of transcription factors which regulates the expression of target genes. The 
steroid hormone receptor (SHR) subgroup includes estrogen receptor α and β, cotrisol: 
glucocorticoid receptor, aldosterone: mineralocorticoid receptor, progesterone: PR and 
dihydrotestosterone: androgen receptor. 
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Structure of Estrogen Receptor. 
The estrogen receptor is a ligand-activated transcription composed of several domains important 
for hormone binding, DNA binding and activation of transcription. Human ER alpha and ER beta 
are encoded by different genes located on different chromosomes. The human estrogen receptor 
gene, located at 6q24. 1, has been cloned, sequenced, and expressed in a variety of cell lines, and 
site-directed mutagenesis has identified domains which are highly conserved across species that 
are responsible for hormone or DNA binding and transcriptional activation.  
Figure 1. Schematic diagram of Estrogen Receptor alpha (ERα) and Estrogen Receptor Beta 
(ERβ) with the identified activated functions (AF) that bind coactivators, DNA binding domain 
(DBD) and ligand binding domain (LBD).  
Both ER α and ER β like all the members of the nuclear receptor super family, are modular  
proteins sharing  some common domains, named A/B, C,D and E/F. The N-terminal domain is 
involved in activation of gene transcription. The DNA binding domain (DBD/C) allows ER to 
dimerize and bind to the specific Estrogen response element sequence on DNA through two Zinc 
finger structures. The hinge domain is involved in receptor dimerization. The ligand binding 
domain, Estrogen binding domain together with N-terminal domain mediates the regulation of 
gene transcription. The ERα and the ERβ isoforms have the most contradictory functions, with 
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ERα having a growth promoting action and ERβ having a growth-inhibitory action in certain 
tissues (Weihua Z et al., 2003, Onate SA et al., 1995). Consequently, the tissue-selective ratio of 
ERα/ERβ can provide a tissue-selective function. 
Genomic actions of Estrogens 
The “genomic action” of steroid hormones occurs after a time lag of at least 2 hours after E2 
stimulation and explains some of hormone functions in physiological and pathological situations.  
Upon binding of estrogen to its ER, it induces conformational change. Intracellular ligand-bound 
SHRs recognizes specific sites on chromatin, referred to as hormone response elements (HREs) 
located within the promoter or enhancers of target genes. This ligand bind SHR translocates as 
homo/heterodimer and binds promoter regions of the target genes thereby regulates gene 
transcription. (Simoncini.Tet al., 2003). 
Figure 2. General Estrogen receptor mechanism.The mechanism behind estrogen action at the 
cellular level starts with an estrogen (ligand) entering the cell and the nucleus and binding to 
estrogen receptor isoforms (ER α or ER β) via their respective "Ligand Binding Domain" (LBD). 
Subsequently, the receptor dimerizes and binds via its "DNA Binding Domain" (DBD) to specific 
sequences on the DNA called "Estrogen Receptor Elements" (ERE). Parallel to the binding of the 
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ER to the ERE, a number of co-activators and/or co-repressors bind to the ligand bound ER, 
enhancing or repressing its transcriptional activity.  
Rapid Non Genomic actions of steroid hormones. 
Various signaling pathways are activated upon E2 binding to ERs. These rapid events may be 
classified into four main signaling cascade: Phospholipse C (PLC)/protein Kinase C (PKCs), 
Ras/Raf/MAPK, phosphatidyl inositol 3 kinase (PI3K)/AKT and cAMP/protein kinase A (PKA) 
activation. The non-genomic effects of estrogen can regulate different cellular processes, such as 
proliferation, survival, apoptosis, and differentiated functions in diverse cell types, including breast 
cancer cells(Bjoinstorm L 2005, Driggers PH 2002, Hall JM 2001, Hayes MP 2000).Non genomic 
actions of steroid hormones are mediated by recruitment of signaling pathways associated with cell 
membrane receptors such as GPCR, ion channels or enzyme linked receptors (Watson CSet al., 
1999). Through the recruitment of various membrane receptors, steroids rapidly mediate multiple 
cellular functions including the functions mediated by phosphorylation or dephosphorylation of 
several regulatory proteins thereby mediate non genomic cellular proliferation, migration and 
invasion (CastoriaG et al., 1999).  Non-genomic signaling by steroid hormones are particularly 
important in tissue sites where there are  relatively lower concentration of SRs (Ciocca DR 
&Vargas RoigLMet al., 1999). 
Non genomic regulation in different cell settings. 
The physiological significance of rapid membrane starting pathways has been clarified at least for 
some E2 targets. In the nervous system, E2 affects neural functions in part by inducing such rapid 
responses. In the skeleton, ER alpha present in caveolae of bone forming osteoblasts, transmits 
survival signals through activation of the Src /Shc/ERK pathway and prolongs the life span of 
osteoblasts. At the same time, E2 delivers a pro-apoptotic signal to bone resorbing osteoclasts, 
shortening their life span. These results suggest that ER rapid signaling actions have also a role in 
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in vivo. In the liver, rapid E2-induced signals (i.e. PLC/PKC) are deeply linked to the expression of 
the LDL receptor and to a decreased level of serum LDL-cholesterol. Finally, vascular protection 
by E2 in ischemia/reperfusion injury in vivo requires E2 induced activation of endothelial NOS, as 
mediated by the PI3K/AKT pathway. 
Estrogens and cardiovascular system 
The cardiovascular actions of estrogens are prominent, but incompletely understood (Mendelsohn 
and Karas, 2005; Arnal et al., 2009; Luksha and Kublickiene, 2009; Simoncini, 2009). The 
presence of estrogen receptors (ERs) and of enzymes involved in estrogen synthesis in human 
blood vessels and endothelium is recognized (Diano et al., 1999). Between the many actions of 
estrogens on the vascular wall, facilitation of endothelial recovery after injury has been one of the 
first to be established (Mendelsohn and Karas, 2005; Arnalet al., 2009; Luksha and Kublickiene, 
2009; Simoncini, 2009). 
A number of studies show that estrogens enhance endothelial proliferation at sites of vascular 
injury, promoting endothelial recovery after structural damage (Mendelsohn and Karas, 
2005; Arnal et al., 2009; Luksha and Kublickiene, 2009). This has been related to the activation of 
both long-term genomic actions and rapid signaling by estrogens through ERs (Mendelsohn and 
Karas, 2005; Arnal et al., 2009; Luksha and Kublickiene, 2009) or through the G-protein-coupled 
receptor 30 (GPR30) (Prossnitz and Maggiolini, 2009), but the mechanistic explanation of these 
processes has been scarcely investigated. The actin cytoskeleton forms the backbone of the cell, 
and its spatial organization is crucial for cell movement and migration. Modification of the form 
and positioning of actin fibers and their relationship with membrane-anchoring structures such as 
integrins and focal adhesion complexes allows cell movement in the extracellular environment 
(Pollard and Cooper, 2009). We have recently shown that estrogen controls actin remodeling in 
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human endothelial cells and the development of specialized membrane structures such as ruffles 
and pseudopodia, thus inducing endothelial cell migration (Simoncini et al., 2006). These 
phenomena depend on the activation of the actin-regulatory protein moesin (Simoncini et al., 
2006). 
Related to this set of actions of estrogens, another important factor of cell-membrane remodeling 
and cell movement is the turnover of focal adhesion complexes. These structures are dynamic in 
nature and their formation and breakdown are regulated by different stimuli, particularly by 
tyrosine kinases (McLean et al., 2005). 
Estrogen exerts pleiotropic functions on the cardiovascular system through binding to estrogen 
receptors (ERs). Traditionally, ERs have been recognized as transcription factors regulating the 
expression of target genes. In the past decades, however, numerous studies have revealed rapid 
actions of estrogen in different systems, especially in non-reproductive tissues such as the 
cardiovascular system. At this level, estrogen triggers rapid vasodilatation, exerts anti-
inflammatory effects, regulates vascular cell growth and migration, and confers protection to 
cardiomyocytes. These so-called 'extra nuclear actions do not require gene expression or protein 
synthesis and are independent of the nuclear localization of ERs. Indeed, some of these actions are 
elicited by ERs residing at or near the plasma membrane. Through complex interactions with 
membrane-associated signaling molecules lead to the activation of downstream cascades such as 
mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-OH kinase (PI3K). These 
cascades are responsible for important cardiovascular actions of estrogen, for instance, the 
activation of nitric oxide synthesis or the remodeling of the endothelial actin cytoskeleton. 
Moreover, these cascades play crucial roles in regulating the expression of target proteins 
implicated in cell proliferation, apoptosis, differentiation, movement and homeostasis. Recent 
advancements in the characterization of the molecular basis of the extra-nuclear signaling of 
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estrogen help us to understand the biological functions of estrogen and would be beneficial in 
elucidating current controversies on estrogen's clinical efficacy in the cardiovascular system. 
Estrogens and breast cancer. 
Breast cancer metastasis is a life threatening stage of cancer and is the leading cause of death in 
advanced breast cancer patients. Estrogen signaling and the estrogen receptor (ER) are implicated 
in breast cancer progression, and the majority of the human breast cancers start out as estrogen 
dependent and express estrogen receptor. Endocrine therapy has been shown to have a positive 
effect on the treatment of ER positive breast cancer. Despite these positive effects, initial or 
acquired resistance to endocrine therapies frequently occurs with tumors recurring as metastatic. 
Tumor metastasis includes a series of biological processes that migrates tumor cells from the 
primary neoplasm to a distant location and involves a multistep cascade of coordinated cell 
adhesion and contractility. Although substantial information is available on the process of 
metastasis, the molecular basis of breast cancer progression to metastasis and the role of estrogen 
signaling in this process remain poorly understood.  
Estrogens and cell movement  
Cell movement is required in relevant physiological processes such as embryonic development, 
tissue and organ differentiation, inflammation, immune response and wound healing, along with 
pathological phenomena, such as cancer metastatic spread. Cell motility is tightly controlled by a 
complex and often redundant array of intracellular signaling pathways largely devoted to the 
dynamic regulation of the actin cytoskeletal network and of its relationship with the cell membrane 
and the extracellular matrix. Sex steroids, particularly estrogen, are effective regulators of cell 
growth, proliferation, migration and tissue organization. Cells respond to the environment through 
the expression of trans-membrane receptors that sense extracellular stimuli and activate an 
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elaborate network of intracellular signaling molecules. Given the large number of different 
signaling molecules and the complex relationships between them, a major challenge is to 
understand how specific signals generate unique responses. Recent evidence indicates that this is 
in part obtained through the regulation of the cytoskeleton. Intriguingly, many of these regulatory 
actions related to cell movement are achieved through rapid, non-classical signaling of sex steroid 
receptors to kinase cascades, independently from nuclear alteration of gene expression or protein 
synthesis. The identification of the mechanistic basis for these rapid actions on cell cytoskeleton 
and cell movement has special relevance for the characterization of the effects of sex steroids in 
physiological conditions, such their role in the control of inflammation, brain or vascular cell 
remodeling, angiogenesis or wound healing, as well as in the context of pathological conditions 
such as steroid-sensitive cancer cell invasion and metastasis. 
Figure 3. Mechanism of cell migration. 
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The ability of cancer cells to move and invade the surrounding environment is the basis of local 
and distant metastasis. Cancer cell movement requires dynamic remodeling of the cytoskeleton and 
cell membrane and is controlled by multi-protein complexes including focal adhesion kinase 
(FAK) or Moesin). 
The architecture of signaling networks plays an important role in achieving signaling specificity 
The control of cell morphology and of the interaction of the cell with the extracellular environment 
requires a number of regulators orchestrating the different cytoskeletal components and their 
interactions with the cell membrane and with anchorage proteins. Recent findings indicate that 
extra-nuclear signaling of estrogen is a fundamental regulator of cell morphology in diverse 
cellular lines, including endothelial cells, breast cancer cells and neuronal cells and that many of 
these actions are played via rapid signaling to the actin cytoskeleton achieved via actin recruitment 
These morphological modifications are tightly dependent on the generation of dynamic structural 
changes of the actin cytoskeleton, via actin polymerization and de-polymerization that also 
represent the starting platform for other important cellular processes such as cytokinesis, adhesion 
and motility. When a cell remodels its shape, the actin cytoskeleton is reorganized, and protrusive 
membrane structures, such as lamellipodia and filopodia, are formed at the leading edge. These 
structures generate locomotive force in migrating cells and are critical in the generation of cell–cell 
interconnections. 
Previous studies have shown the importance of PAI-1 on cellular migration in vascular smooth 
muscle cells. Peter Carmeliet et al have shown that, by affecting cellular migration, PAI-1 plays 
inhibitory role in vascular wound healing and arterial neo intima formation after injury and 
adenoviral transfer of PAI-1 gene reduces arterial neo intima formation in mice, however, in the 
issue of Arteriosclerosis, Thrombosis, and Vascular Biology, Tanaka and colleagues presented 
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data indicating that PAI-1 can paradoxically enhance, rather than impair, smooth muscle cell 
migration under selective circumstances.  
In conclusion, estrogens controls different target cells through rapid and genomic signaling 
pathways. The cell context specific environment (e.g., differentiation, ER level, and ER co-
expression) has an impact on the integration of rapid signaling by E2 from the membrane and on 
subsequent nuclear transcription. This leads to different signal cascades, different gene expression 
in response to the same hormone,  and different cell biological outcome. My Ph.D thesis comprises 
of two different projects which focuses on new ways of conventional and unconventional role of 
estrogens in the modulation of cell movement in different cell types. 
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PART-I 
             ESTROGEN REGULATES ENDOTHELIAL MIGRATION VIA  
                        PLASMINOGEN ACTIVATOR INHIBITOR (PAI-1) 
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ABSTRACT 
Aim: Endothelial plasminogen activator inhibitor (PAI-1) controls vascular remodeling, 
angiogenesis and fibrinolysis. PAI-1 blood levels in women are related to estrogen. The aim of this 
study is to characterize the signaling pathways through which estrogen regulates PAI-1 in 
endothelial cells. Furthermore, we aimed to investigate whether PAI-1 is implicated in the control 
of endothelial migration by estrogen. 
Methods: Cultured human endothelial cells (HUVEC) and ovariectomized rats were used to test 
the effects of 17β-estradiol (E2) on PAI-1 expression and its role on endothelial migration. 
Results: At physiological concentrations, E2 increases expression of PAI-1 in HUVEC within 6-12 
hours through activation of a signaling cascade initiated by ERα and involving G proteins, 
phosphatidylinositol 3-OH kinase (PI3K) and Rho-activated kinase-II (ROCK-II). ROCK-II 
activation turns into an over-expression of c-Jun and c-Fos that is required for E2-induced 
expression of PAI-1. Estrogen-induced PAI-1 expression is implicated in HUVEC horizontal 
migration. PAI-1 regulation is found also in vivo, in female rats, where ovariectomy is associated 
with reduced PAI-1 expression, while estrogen replacement counteracts this change. 
Conclusions: Estradiol increases PAI-1 synthesis in human endothelial cells and in rodent aorta 
through a G protein-initiated signaling that targets early-immediate gene expression. This 
regulatory pathway is implicated in endothelial cell migration. These findings describe new 
mechanisms of action of estrogens in the vessels, which may be important for vascular remodeling 
and heamostasis. 
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INTRODUCTION 
Plasminogen activator inhibitor-1 (PAI-1) is a serine protease inhibitor (SERPIN)that controls the 
fibrinolytic system by inhibiting tissue-type and urokinase plasminogen activators(Bergheim et al. 
, 2006, Dimova and Kietzmann, 2008, Xu et al. , 2010, Zorio et al. , 2008). By controlling the 
plasminogen cascade, PAI-1 is also implicated in physiological and pathological vascular 
processes such as thrombosis, inflammation, vascular remodeling and wound healing (Diebold et 
al. , 2008). A prominent source of PAI-1 in these conditions is represented by vascular endothelial 
cells, which synthesize the protease inhibitor in response to a variety of stimuli (Gramling and 
Church, 2010, Lyon and Hsueh, 2003, Marx et al. , 1999, Stiko-Rahm et al. , 1990, Ye et al. , 
2002).  
Beyond being a modulator of the fibrinolytic cascade, PAI-1 has been recently identified as a 
controller of cell movement and migration. Modulation of cell migration and angiogenesis by PAI-
1 appears to be implicated both in vascular remodeling (Diebold, et al., 2008) as well as in 
promotion of tumor growth, invasion and metastasis (Kwaan and McMahon 2009). This newly 
identified set of activities is exerted through interactions with cell surface receptors affecting cell 
motility as well as through multifaceted interactions with extracellular matrix proteins (Czekay, 
etal., 2011). In addition, signaling events that turn into modifications of the shape of the 
cytoskeleton and of the cell membrane modulate the expression of PAI-1 (Samarakoon, et al., 
2010). A link exists between estrogen concentrations and PAI-1 in women. Menopausal estrogen 
withdrawal is associated with increased blood levels of PAI-1, while a decrease is found with 
estrogen therapy (Gebara, et al., 1995)(Koh, et al., 1997)(Sowers, et al., 2005a). These changes 
have been interpreted as potential reasons for the beneficial vascular effects of endogenous 
estrogens in fertile women (Sowers, et al., 2005b). In addition, a link between PAI-1 and hormonal 
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status has been identified in the presence of coronary heart disease in women (Grancha, et al., 
1999) and experimental animals (Chua, et al., 2011). 
On the other side, PAI-1 is also a known negative prognostic factor in endocrine sensitive cancers, 
such as breast (Manders, et al., 2004)(Eljuga, et al.,2011), and endometrial cancer (Steiner, et 
al.,2008), with higher expression of the protease inhibitor being associated with poorer response to 
chemotherapy and prognosis. Based on preliminary evidence, estrogen seems to cross talk with 
growth factors in regulating PAI-1 synthesis in breast cancer cells (Burdette and Woodruff 2007), 
but little is known on the signaling mechanisms through which estrogen controls PAI-1 nor is this 
regulatory action extends to other cell types. 
The purpose of the current study was to explore the regulatory actions of estrogen on PAI-1 in 
human endothelial cells and to characterize the signaling steps through which these actions are 
enacted.  
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MATERIALS AND METHODS 
Cell cultures and Treatments 
Human umbilical vein endothelial cells were extracted with collagenase. HUVEC were seeded in 
Dulbecco’s Modified Eagle’s Medium (DMEM) containing fetal bovine serum (FBS) for 24 hours. 
Before experiments investigating transcriptional effects, medium was replaced by DMEM 
containing 10% FBS stripped with charcoal for 4-6 h. Whenever an inhibitor was used, the 
compound was added 30 minutes before starting the active treatments. 17β Estradiol (E2), pertussis 
toxin (PTX), ICI 182,780 (ICI), 4,49,40-(4-propyl-[1H]-pyrazole-1,3,5-triyl) trisphenol (PPT) and 
2,3-bis(4-hydroxyphenil)-propionitrile (DPN), Phosphatidylinositol 3-OH kinase inhibitor 
(Wortmannin), Rho kinase inhibitor (Y-27632) were from Sigma-Aldrich (Saint-Louis, MO). 4-
amino-5-(4-chlorophenyl)-7-(t-butyl) pyrazolo (3,4-d) pyrimidine, (PP2) and PD98059 was 
purchased from Calbiochem (Nottingham, UK).  
Animal treatments 
Fertile female Wistar rats, weighing 175–199 g (Harlan,S. Pietro al Natisone, Italy), were kept 
under 14 h of illumination per day (06.00–20.00 h) and had free access to standard rat chow and 
tap water. After 14 days the rats were either sham-operated or ovarectomized in the same oestrous 
cycle stage. Ovariectomized rats were treated with E2 at a concentration of 0.01mg/kg, 0.05 mg/kg, 
and 0.1mg/kg).Estradiol was dissolved in pure ethanol and administered orally after dilution in 
water. Animals were euthanized by decapitation under pentobarbital anesthesia (30 mg/kg) and 
abdominal aorta was dissected. Aortas were snap-frozen in dry ice and stored at -80 C. Animals 
were maintained in accordance with the National Institutes of Health Guide for the Care and Use 
of Laboratory Animals (www.nap.edu/readingroom/books/labrats). 
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Immunoblottings 
After treatments, cells were lysed with lysis buffer containing Sodium Dodecyl Sulfate (SDS), 
glycerol and Tris-EDTA. The concentration of total protein was quantified by Bichinconic acid 
(BCA) assay, and 30µg of proteins were loaded into each well and separated by denaturing SDS-
PAGE. Antibodies against the following proteins were used: c-Fos (sc-448), c-Jun (sc-74543), 
Actin, all from Santa Cruz Biotechnology (Santa Cruz, CA), PAI-1 (ab82218), ERα (ab2746) and 
ERβ (ab288)were purchased from Abcam (Cambridge, UK). Primary and secondary antibodies 
were incubated with the membranes, followed by three 5-min washes with TBS-Tween 20. 
Immunodetection was accomplished using enhanced chemiluminescence and was recorded with a 
quantitative digital imaging system (Quantity One; BioRad, Hercules, CA) 
Gene silencing with RNA interference 
Gene silencing was performed using synthetic siRNAs targeting c-Fos, c-Jun or ERβ purchased 
from Santa Cruz. ERα siRNAs were from Dharmacon (Lafayette, CO). All siRNAs were used at 
the final concentration of 30nM according to the manufacturer’s instructions. HUVEC were 
transfected with Lipofectamine 2000 (Invitrogen, Carlsbad, CA) in opti-MEM without antibiotics 
or anti-mycotics. Efficacy of gene silencing was checked by western blotting. Viability of cells 
was checked throughout transfection experiments. 
Transfection experiments 
Dominant negative Gα13(Gα13Q226L/D294N) was obtained from the Guthrie DNA Resource 
Center (www.cdna.org). The insert was cloned in pcDNA3.1+. The plasmid (10 µg) was 
transfected into HUVEC cells using Lipofectamine (Invitrogen). Cells were treated 48 h after 
transfection. 
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Cell migration assays 
Cell migration was assayed with razor scrape assays as previously described (Xiao-dong fu et al 
2008). Briefly, a razor blade was pressed through the confluent T47-D breast cancer cell 
monolayer into the plastic plate to mark the starting line. T47-D cells were swept away on one side 
of that line. Cells were washed, and 2.0 mL of DMEM containing steroid-deprived FBS and 
gelatin (1 mg/mL) were added. Cytosine b-D-arabinofuranoside hydrochloride (Sigma)(10 mM), a 
selective inhibitor of DNA synthesis which doesn’t inhibit RNA synthesis was used 1 h before the 
test substance was added. Migration was monitored for 24 hours. Every 12 h fresh medium and 
treatment were replaced. Cells were digitally imaged and migration distance was measured by 
using phase-contrast microscopy. 
Statistical analysis 
All values are expressed as Mean ± SD. Statistical differences between mean values were 
determined by ANOVA, followed by the Fisher's protected least significance difference (PLSD). 
All differences were considered significant at P<0.05. 
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RESULTS  
Figure 1. E2 induces PAI-1 expression in endothelial cells via estrogen receptor α. 
Human umbilical vein endothelial cells (HUVEC) were treated with 17-β estradiol (E2) for 
different times and protein lysates were obtained. Expression of PAI-1 gradually increased during 
exposure to estradiol and peaked at 24-48 hours (Fig 1A). Endothelial PAI-1 expression was 
increased in the presence of physiological concentrations (Fig 1B).  
In order to check which estrogen receptor isoform mediates the induction of PAI-1 we silenced ERα 
or ERβ with small interfering RNAs. Silencing of ERα blocked PAI-1 induction by E2 (Fig 1C), 
whereas silencing of ERβ was ineffective (Fig 1D).   
Figure 1. A) HUVEC were treated with E2 for different times (0-72 hours). B) HUVEC was 
treated with different concentrations of E2 (10
-11
 – 10
-6
M). C-D) HUVEC were transfected with 
ERα or ERβ siRNAs for 48 hours before the addition of E2 1nM for an additional 24 hours protein 
extracts were analyzed with Western technique for expression of PAI-1,  Actin, ERα and ERβ. 
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Figure 2. E2 induces PAI-1 through up-regulation of c-Fos and c-Jun. 
PAI-1 gene promoter region is controlled by c-Jun and c-Fos through two dedicated consensus 
sequences. We checked whether E2 regulates PAI-1 through these transcription factors performing 
time course experiments with 1 nM E2 and analyzing expression of c-Fos and c-Jun in HUVEC. E2 
induced the expression of c-Fos and c-Jun as early as after 2 hours, with a peak at 8 hours (Fig 2 A-
B). In parallel, silencing of c-Fos and c-Jun with siRNAs blocked PAI-1 induction by E2 (Fig 2 C-
D).  
Figure 2. A-B) HUVEC were treated with 1nM E2 for different times. C-D) HUVECs were 
transfected with siRNAs targeted against c-Fos and c-Jun (30 nM) for 30 hours before the addition 
of E2 for an additional 24 hours E-F) HUVEC were treated with 10 µM Y27632, 30 nM 
Wortmannin (WM) and 100 ng/ml pertussis toxin (PTX). Protein extracts were used to quantitate 
expression of c-Fos, c-Jun, Actin and PAI-1 with Western analysis. 
 
Santhosh.Gopal  -  Rapid signaling of conventional and unconventional estrogen receptors to the actin cytoskeleton and cell movement 
25 
 
Figure 3. E2 regulates c-Jun, c-Fos and PAI-1 expression via signaling to G proteins, 
Phosphatidylinositol-3-OH-kinase and Rho –associated kinase II. 
To search for the signaling pathways involved in E2 mediated c-Fos and c-Jun induction, we 
blocked different signaling intermediates that have an established role in regulating c-Jun and c-
Fos. E2 failed to induce c-Fos expression in HUVEC when G proteins, PI3K or ROCK-II were 
inhibited with pertussis toxin (PTX), wortmannin (WM) or Y27632, respectively (Fig 2E). Similar 
results were found with c-Jun (Fig 2 F). 
In agreement, the increased expression of PAI-1 associated with E2 treatment was prevented by 
PTX, wortmannin or PP2, which blocks the activity of the PI3K controller, c–Src (Fig. 3A). As a 
control, the PP2–related, inactive compound, PP3, was ineffective (Fig. 3A). In addition, 
transfection of HUVEC with a dominant negative Gα13 construct indicated that E2 uses Gα13 to 
induce PAI-1 expression (Fig. 3B). 
 
Figure 3.A) HUVEC were treated with the c-Src inhibitor, PP2, the inactive PP2-analogue PP3 
(5µM), with the PI3K inhibitor, wortmannin (WM, 30nM) or with the G proteins inhibitor, 
pertussis toxin (PTX -100 ng/ml). B) HUVEC were transfected with a dominant negative construct 
(Gα13 D294N) for 48 hours using Lipofectamine before the addition of E2 for a additional 24 
hours. Protein lysates were used to check for expression of PAI-1, Gα13 and Actin with Western 
analysis.
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Figure 4. E2controls PAI-1 via ROCK-2 
Administration of either normal E2 or of a membrane-impermeable form of E2 (E2 covalently cross- 
linked to bovine serum albumin, E2-BSA) to HUVEC turned into increased expression of ROCK-2 
and its expression was blocked by the ER antagonist (ICI 182,780). As a control, the ROCK–2 
inhibitor Y27632 did not block the increase of expression of ROCK–2 associated with E2 (Fig. 4A). 
Consistent with this result E2 as well as E2-BSA induced PAI-1 expression through ROCK–2, as 
shown by the loss of effect in the presence of Y27632 (Fig. 4B).  
Figure 4. A) HUVEC were treated with the estrogen receptor antagonist ICI 182,780 10 nM and 
with the ROCK-2 inhibitor Y27632 (10 µM) for 30 minutes before the addition of E2 (1nM) or of 
E2 conjugated with BSA (E2-BSA-1nM) for additional 24 hours. B) HUVEC were treated with 
ICI 182,780 (10 nM) or Y27632 (10 µM) for 30 minutes before the addition of E2 or E2-BSA for 
additional 24 hours. Protein extracts were obtained and used with western analysis to control 
expression of Rock-2 or PAI-I 
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Figure 5. E2 regulates PAI-1 expression in vivo. 
To check whether estrogen also regulates PAI-1 in an in vivo setting, we administered E2 at different 
doses for 14 days to ovariectomized (OVX) rats, and compared the expression of PAI-1 in the 
abdominal aorta versus that of intact or of placebo-treated OVX rats. PAI-1 expression was present 
in the aorta of fertile rats and was decreased in OVX rats. OVX rats treated with oral E2 showed a 
dose-related increase of PAI-1 expression in the abdominal aorta (Fig. 5).  
 
Figure 5. Ovariectomized mice were fed with 17β-estradiol at different doses (0.01, 0.05 or 0.1 
mg/kg) for 14 days. Abdominal aorta was obtained after sacrifice sham-operated fertile mice and 
placebo-treated ovariectomized mice served as controls. 
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Figure 6. E2 induces endothelial cell migration through PAI-1.  
HUVECs were culture dish and then treated with 1nM E2. The mean migration distance from the 
starting line taken from 5 random microscopic fields was assayed  and expressed as mean  ±  SD. 
Average  migration distance  ±  SD was expressed as the ratio between active treatments and 
control. Representative images are shown and the mean migration distance is shown in bar 
graphs.* = p<0.05 vs. E2(non-silenced cells). 
 
 
Figure 6. HUVECs were transfected with siRNAs against PAI-1 for 48 hours. Endothelial cells 
were scraped from the culture dish and then treated with 1nM E2. The mean migration distance 
from the starting line taken from 5 random microscopic fields was assayed and expressed as mean 
± SD. Average migration distance ± SD was expressed as the ratio between active treatments and 
control.  Representative images are shown and the mean migration distance is shown in bar 
graphs.* = p< 0.05 vs. E2 (non-silenced cells). 
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DISCUSSION 
This paper identifies a direct regulation of PAI-1 expression by estradiol in human endothelial 
cells, which is exerted through an extra-nuclear signaling to the early-immediate genes c-Jun and 
c-Fos. 
Regulation of PAI-1 by estrogen has been suggested in a variety of clinical settings; however, it is 
unclear how this hormone directs PAI-1 expression in tissues. A recent paper indicates that in 
endothelial cells estrogen has a double-sided effect on PAI-1, triggering its expression through 
ERα while repressing it through ERβ (Smith, et al. 2004). We here extend this concept showing 
that estrogen drives ERα to enact rapid, extra-nuclear signaling involving G proteins and the Rho-
A-associated kinase (ROCK-2). The cross talk between this cytoplasmic recruitment of ROCK-2 
and the subsequent activation of c-Jun and c-Fos expression mediates PAI-1 increase in endothelial 
cells. This proposed regulatory pathway is consistent with the published hypothesis of a prominent 
role of ERα as positive regulator of PAI-1. Furthermore, it provides possible ways to selectively 
modulate PAI-1 in endothelial cells by either using preferential ERα or ERβ ligands, or by 
associating pharmacological tools that interfere with the rapid signalling of ERα to ROCK-2. Such 
strategies may be helpful in conditions where estrogen-related induction of PAI-1 may either be 
desirable or undesirable. 
Endocrine-sensitive cancers, such as breast or endometrial cancer, represent a straightforward 
situation where PAI-1 induction linked to estrogen may be unwanted (Manders, et al. 
2004)(Eljuga, et al. 2011)(Steiner, et al. 2008). Inactivation of ERα-mediated signaling could turn 
into reduced ability to remodel the extracellular matrix and decreased cancer cell motility, thus 
possibly leading to less efficient cancer progression. If this hypothesis holds, our findings may 
suggest a role of endothelial cell-derived PAI-1 as a possible target of estrogen to support cancer 
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progression. However, our unpublished data (Gopalet al, personal communication) as well as work 
by others (Burdette and Woodruff 2007) suggest that estrogen also increases PAI-1 expression 
directly in breast cancer cells. This fits with the mounting evidence that sex steroids are effective 
enhances of cancer cell motility and invasion through a multi-modal control of cytoskeletal 
remodeling, membrane shaping and, now, extracellular matrix turnover (Flamini, et al. 2011; 
Sanchez, et al. 2010). 
It is less clear how our results fit with the large body of evidence that endogenous or exogenous 
estrogens decrease PAI-1 blood levels (Gebara, et al. 1995)(Koh, et al. 1997) Our findings suggest 
that, contrary to what previously thought, estrogen-related decrease in circulating PAI-1 is not 
explained by an endothelial effect, but may rather rely on other phenomena, such as modified 
metabolic clearance or reduced production in other tissues (may be because of local prevalent ERβ 
activity). 
However, increased endothelial-derived PAI-1 may still represent a biologically important mean 
through which estrogens regulate vascular function. Indeed, this action may result into locally 
reduced fibrinolysis, which may contribute to the pro-thrombotic actions of estrogens in veins 
(Mendelsohn 2002). On the other side, PAI-1-mediated extracellular matrix remodeling may add 
to the previously identified stimulatory effects of estrogens on endothelial cell motility (Simoncini, 
et al. 2006), thus helping arterial re-endothelialization processes, and thus affect the incidence of 
arterial events in women. 
In conclusion, this paper provides new molecular cues on how estrogens control PAI-1 in 
endothelial cells. These findings may help to develop new therapeutic strategies to reduce 
unwanted side effects of estrogens in the cardiovascular system or on endocrine-sensitive cancers. 
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PART-II 
 
             THE ROLE OF UNCONVENTIONAL ESTROGEN RECEPTORS   
                IN CELL MOVEMENT IN ER NEGATIVE BREAST CANCER 
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ABSTRACT 
Aim: The aim of this study is to characterize the signaling pathways through which estrogen 
induces actin remodeling in ER negative MDA MB468 cells. Furthermore, we aimed to investigate 
whether the E2 induced phosphorylation of Moesin and FAK is implicated in the control of cell 
invasion and metastasis. 
Methods: Cultured human MDA MB 467 cells were used to test the effects of 17β-estradiol (E2) 
on FAK and Moesin phosphorylation and its role on actin remodeling. 
Results: At physiological concentrations, E2 induces phosphorylation of Moesin and FAK in 
MDA MB468 cells within 30 minutes through rapid non genomic activation of a signaling cascade 
initiated by GPER and involving G proteins, phosphatidylinositol 3-OH kinase (PI3K) and Rho-
activated kinase-II (ROCK-II). ROCK-II activation turns into E2-induced phosphorylation of 
Moesin and FAK, thereby remodels actin filaments implicated in cell migration.  
Conclusions: Estrogen induces phosphorylation of Moesin and FAK without the presence of 
endogenous Estrogen receptors viz ERα and ERβ in MDAMB468 cells. Our preliminary work 
clearly confirms the previous results reported by Filardo et al about GPER as estrogen receptors. 
We characterized the signaling events by which estrogen 17β estradiol induces Moesin and FAK 
phosphorylation. These regulatory pathways is implicated in remodeling of actin cytoskeleton and 
cell movement and invasion in ER negative breast cancer cells. These findings describe new 
mechanisms of action of estrogens in actin remodeling, in ER negative breast cancer cells, which 
may enable us to provide therapeutic strategies for ER negative breast cancer cells. 
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INTRODUCTION 
Estrogens are important regulators of breast cancer cell progression. Many of the effects are 
mediated by the classical estrogen receptors viz ERα and ERβ, where they mediate genomic 
effects. In addition, it is well known that estrogens can induce rapid effects, which do not mediate 
gene transcription, since responses occur within seconds or minutes (Szegoet al., 1967; Pietras et 
al., 1977). Depending on the cell type, the rapid responses to estrogen involve mobilization of 
various second messengers, e.g. cAMP, Ca
2+
, PI3kinase (Morley et al., 1992; Lieberherr and 
Grosse, 1994).interaction with membrane receptor, e.g. the epidermal growth factor (EGF) 
receptor, or activation of intracellular kinase pathways (Nelson et al., 1991; Migliaccioet al., 1996; 
Ho and Liao, 2002). Such observations suggested that a G protein-coupled receptor (GPR) 
mediated these fast effects. GPRs represent one of the largest and most diverse super-families of 
cell membrane receptors in mammals, and they respond to a great variety of ligands. 
G-protein coupled receptor (GPR30) also known as G-protein coupled estrogen receptor 1. The G 
protein-coupled estrogen receptor 1 (GPER) was first cloned in 1996 and initially named GPR30 
(Owmanet al., 1996). GPR30 is an integral membrane protein that displays high affinity towards 
estrogens. GPR30 is encoded by GPER gene. This protein is a member of the rhodopsin like 
family of G protein-coupled receptors which binds estrogen, resulting in intracellular calcium 
mobilization and synthesis of phosphatidyl inositol (3,4,5)-triphosphate in the nucleus. This 
protein therefore plays a role in the rapid non-genomic signaling events widely observed following 
stimulation of cells and tissues with estrogen. The distribution of GPR30 is well established in the 
rodent, with high expression observed in the hypothalamus, pituitary gland, adrenal medulla, 
kidney medulla and developing follicles of the ovary (Hazell GGJ et al., 2002). 
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GPR30 sub-cellular localization 
Although many GPCRs are localized in the plasma membrane, some GPCR like nuclear ER, 
localized at intracellular  sites (Gobeil et al., 2006). Using sub-cellular markers Eric Prosnitz 
reported that GPR30 is expressed in intracellular tubule-reticular network. In contrast, previous 
reported the expression of GPR30 in the plasma membrane (Thomas et al., 2005), so there is no 
clear evidence reporting the site of GPR30 expression however it is certainly possible that under 
some conditions, intracellular GPR30 could exist or translocate to the plasma membrane or vice 
versa.  
GPR30 and its ligand 
Since no ligands was known for GPER, it was termed initially as orphan receptor. It was not until 
2000 that possible function for GPER was identified. The proposed role of GPER in response to 
estrogen was based on the correlation of receptor expression with estrogen mediated signaling 
(Ylikomiet al., 2004).  Revankaret al., in 2005, synthesized fluorescent derivative of ethinyl 
estradiol to test the hypothesis that GPR30 binds estrogen by confocal fluorescence microscopy 
and quantitative flow cytometry . They observed that fluorescent derivative of estrogen displays 
subcellular colocalization with ER in the nucleus or GPR30 in endoplasmic reticulum (Revankaret 
al., 2005).  
GPR30 signaling network 
E2 induction leads to activation of SRC kinase, phosphorylation of adaptor protein SHC, and 
through the activation of extracellular release of heparin bound EGF (fig 1).  The release of HB-
EGF allows the activation of MAPK pathway. Accumulating evidence suggest that GPR30 triggers 
short term and long term responses. One of the main early events mediated by E2 is the activation 
of PI3Kinase through GPR30 thereby activating anti apoptotic and anti proliferative AKT. The 
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specific GPR30 antagonist G15 inhibits the stimulation of PI3K by both E2 and GPR30 agonist G1 
in SKBr3 breast cancer cells which endogenously express GPR30. The stimulation of PIP3 by E2 
and G-1 and their inhibition by G15 could also be demonstrated in ER negative COS7 cells 
 
 
Figure 1. GPR30 signaling pathway. Source: Maggiolini M, Picard DJ J Endocrinol 2010;204:105-114. 
 
In ER-negative SKBr3 breast cancer cells, E2 induces c-fos expression through the 
GPR30/EGFR/MAPK signaling cascade (Maggiolini et al., 2004).E2 and the partial ER antagonist 
hydroxyl tamoxifen  (OHT) both stimulate the expression of c-fos and elicit proliferative effects 
through GPR30 in thyroid and endometrial cancer cells (Vivacqua et al. 2006a,b). In ovarian 
cancer cells, both E2 and G-1 up-regulate numerous estrogen-responsive genes including c-fos, 
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pS2, and cyclins A, D1 and E, while other direct ERα target genes such as the progesterone 
receptor (PR) gene only respond to E2 (Albanito et al. 2007). 
Actin cytoskeleton remodeling 
Actin is a globular protein with an ATP binding site in the center of the molecule. Termed "G-
actin"  the monomer  will dimerize or form a trimer. This serves as a site for nucleation and further 
growth of the actin proto filament.  G-actin forms F-actin (the filament) in the presence of ATP, 
Mg and K. The concentration of G-actin is also critical.  Above the critical concentration Cc of G-
actin, the molecules will polymerize. ATP hydrolysis is not required for polymerization, but it is 
required to promote de-polymerization (if it is converted to ADP). In this regard, it behaves like 
microtubules and their need for GTP hydrolysis to de-polymerize. The plus end of  G-actin is the 
end that is opposite the cleft that holds the ATP molecule.  The minus end is the opposite end.  
Growth and polymerization is more rapid at the plus end.  If you add a solution containing myosin 
to actin filaments, they will "decorate the filaments" and they will be pointing in the direction of 
the plus end. Two actin molecules bind weakly, but addition of a third stabilizes the complex. This 
trimer then adds additional molecules and forms a "nucleation site". This is the slow, or lag phase 
of the polymerization process.  One could add fragments of actin filaments to speed this up, in 
vitro.  Or, key actin binding proteins may help to speed this process. Addition of actin molecules to 
form a long helical polymer. After a period of growth, an equilibrium phase is reached in which 
de-polymerization controls the length as new monomers are added. Polymerization of actin 
filaments can occur via a network regulated by filamin. This protein works like a clip to connect 
the filaments at the cross-over points.  Other proteins create bundles of actin filaments. 
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Figure.2. This is the most dense concentration of actin filaments. It lies just under the plasma 
membrane. It interacts with a number of different proteins associated with the membrane as well as 
proteins in signaling pathways. It may also be traversed by myosin as vesicles are brought to the 
periphery for secretion. As stated earlier, it may be organized in a network or bundles, depending 
on the area and the needs of the cell. At specific sites in the cell, the focal adhesions are formed, 
linking the cell to specific matrix proteins. It is this region that is primarily responsible for forward 
movement. 
Cell migration is a key process in the development and maintenance of multi-cellular organisms. 
Tissue formation during embryonic development, wound healing and immune response all require 
the orchestrated movement of cells in particular directions to specific locations. Cell migration is 
required for cancer cell spread, invasion and metastasis and it is achieved through a dynamic 
remodeling of actin filaments and focal adhesion sites (Acconcia F et al., 2006). This process leads 
to rapid changes of cell membrane morphology, with the formation of specialized structures linked 
to cell movement such as pseudopodia and ruffles. Motile cells extend a leading edge by 
assembling a branched network of actin filaments that produces physical force as the polymers 
grow beneath the plasma membrane. Proteins that reconstitute actin cytoskeleton remodeling 
includes actin, Arp 2/3 complex and WASP proteins. WASP proteins regulate the activity of 
Arp2/3 complex to nucleate actin filaments from the side of pre-existing actin filaments. These 
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actin filaments push the membrane forward as they grow at their barbed ends (Pollard TD et al., 
2003). 
We previously characterized the estradiol mediated signaling events that induces actin 
cytoskeleton remodeling. We showed that in ER positive T47D breast cancer cells, estradiol 
induces rapid and dynamic actin cytoskeleton  remodeling with the formation of specialized cell 
membrane structures like ruffles and pseudopodia (Giretti MS et al.,2005). They also showed that 
estradiol mediate actin cytoskeleton remodeling through ERα. This work strongly supports the fact 
that ER is required for estrogen mediated actin cytoskeleton remodeling.  
Since many research work speculates that estrogens uses GPR30 receptor to mediate several 
estrogen mediated signaling events in ER negative breast cancer cells, we studied how estrogens 
induces rapid actin cytoskeleton remodeling in ER negative MDA MB 468 breast cancer cells. 
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MATERIALS AND METHODS 
Cell cultures and Treatments 
MDA MB468 were seeded in L15 medium containing fetal bovine serum (FBS) for 24 hours. 
Before experiments investigating non-transcriptional effects, medium was replaced byL15 with 
without FBS for4-6 h. Whenever an inhibitor was used, the compound was added 30 minutes 
before starting the active treatments. 17β Estradiol (E2), pertussis toxin (PTX), 
Phosphatidylinositol 3-OH kinase inhibitor (Wortmannin), Rho kinase inhibitor (Y-27632) were 
from Sigma-Aldrich (Saint-Louis, MO). 4-amino-5-(4-chlorophenyl)-7-(t-butyl) pyrazolo (3,4-d) 
pyrimidine, (PP2) and PD98059 was purchased from Calbiochem (Nottingham, UK).  
Immunoblottings 
Cell lysates were separated by SDS-PAGE. Antibodies used were: Moesin (clone 38, Transduction 
Laboratories, Lexington, KY), Thr
558
-P-moesin (sc-12895, Santa Cruz Biotechnology, Santa Cruz, 
CA),pFAK Tyr
397
(BD bioscience). House keeping protein was used as a loading control. All 
primary antibodies were used at a concentration of 1:1000 and secondary antibodies were used at a 
concentration of 1:4000. All HRP conjugated secondary antibodies were purchased from Santa 
Cruz Biotechnology, (Santa Cruz, CA). After transfer, membrane was blocked with 5% BSA in 
TBS Tween 20 for one hour and then incubated with primary and secondary antibodies. 
Immunodetection was accomplished with enhanced chemiluminescence. 
Actin Immunofluorescence 
MDA-MB468 cells were grown on cover slips and transfected with shRNA plasmid encoding 
GPR30. After transfection, cells were exposed to treatments. Cells were fixed and permeabilized 
with Triton X 100 for 10 min. Blocking was performed with 1% BSA for 30 minutes. Cells were 
Santhosh.Gopal  -  Rapid signaling of conventional and unconventional estrogen receptors to the actin cytoskeleton and cell movement 
40 
 
incubated with Texas Red-phalloidin (Sigma). The nuclei were counterstained with or 4′-6-
diamidino-2-phenylindole (DAPI) (Sigma) and mounted with Vecta shield mounting medium 
(Vector Laboratories, Burlingame, CA). Immunofluorescence was visualized using an Olympus 
BX41 microscope and recorded with a high-resolution DP70 Olympus digital camera. After 
conversion to grey scale images, the cell membrane thickness and the gray levels of the 
extracellular area, cell membrane as well as cytoplasm were quantified using the Leica QWin 
image analysis and image processing software (Leica Microsystems, Wetzlar, Germany). 
Transient Transfections 
MDA-MB468 cells were transfected with plasmid (1 µg) using the Lipofectin reagent (Invitrogen, 
Carlsbad, CA) according to the manufacturer's instructions. The transfected plasmids were: 
shRNA plasmids encoding GPR30. The Plasmids were obtained from Origene.  For GPR30, 
transfection efficiency was verified using GFP expression. 60 hours after transfection, cells were 
treated with G1 and E2 and cellular extracts were prepared according to the experiments to be 
performed. 
Cell invasion assay 
Cell invasion were assayed following the standard method by using the BD Bio Coat
TM
 Growth 
Factor Reduced (GFR) MatrigelTM Invasion Chamber (BD Bioscience, USA). In brief, after 
rehydrating the GFR Matrigel inserts, the test substance was added to the wells. 0.5mL of MDA-
MB468 cell suspension (2.5×10
4
 cells/mL) were added to the inside of the inserts. The chambers 
were incubated for 24 h at 37°C, 5% CO2 atmosphere. After incubation, the non-invading cells 
were removed from the upper surface of the membrane using cotton tipped swabs. Then the cells 
on the lower surface of the membrane were stained with Toluidine blue. The invading cells were 
observed and photographed under the microscope at 20X magnification. Cells were counted in the 
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central field of triplicate membranes. The invasion index was calculated as the % invasion test cell/ 
% invasion control cell. 
Statistical analysis 
All values are expressed as Mean ± SD. Statistical differences between mean values were 
determined by ANOVA, followed by the Fisher's protected least significance difference (PLSD). 
All differences were considered significant at P<0.05. 
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RESULTS 
Figure 1. E2 activates Moesin and FAK phosphorylation in ER negative MDA MB 468 breast 
cancer cells 
In order to check at which concentration, 17 β E2 activates phosphorylation of Moesin and FAK, 
we treated MDA MB468 cells with different  concentrations of E2 for 30mins, we found that both 
phosphorylation of Moesin and FAK by E2 at a optimum concentration of 1µ. Fig 1. This clearly 
shows that E2 activates Moesin and FAK phosphorylation even in the absence of endogenous 
estrogen receptors.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Dose dependent experiment.MDA MB 468 cells were treated with E2 at different 
concentrations for 30mins. 
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Figure 2. E2 activates phosphorylation of Moesin and FAK through GPER 
In order to check whether GPER is involved in E2 mediated phosphorylation of Moesin and FAK, 
we silenced the GPER with plasmid encoding GPER shRNA. Figure 2 clearly shows that E2 and 
G1 failed to induce phosphorylation of FAK and Moesin in the cell silenced with GPER shRNA. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. MDA MB 468 cells were transfected with shRNA plasmid against GPER for 48 hours 
and then treated with 1uM E2 for 30mins. 
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Figure 3. E2 activates Moesin and FAK phosphorylation through GPER, PI3K, ROCKII and 
c-SRC pathways 
To search for the signaling pathways involved in E2 mediated activation of phosphorylation of 
Moesin and FAK, we blocked different signaling intermediates that have an established role in the 
activation of phosphorylation of Moesin and FAK, G1 and E2 failed to induce Moesin and FAK 
phosphorylation in MDA MB468 cells when GPER, PI3K, c-SRC and ROCK-II were inhibited 
with G15, WM, PP2 and Y27632, respectively. Where as PD inhibitor does not have any effect 
indicating that E2 mediated phosphorylation of FAK and Moesin is through GPER/PI3K/c-
Src/ROCK2. Fig (3A and 3B) 
 
 
 
Figure. 3a.MDA MB468 cells were treated with G15 (GPER antagonist), PD (MAPK) inhibitor, 
PP2 (c-SRC) inhibitor, Wortmannin (PI3K) inhibitor, Pertussis toxin PTX (G protein) inhibitor, 
Y27632 (ROCK2) inhibitor for one hour before adding E2 for 30mins. 
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Figure. 3b.  MDA MB468 cells were treated with G15 (GPER antagonist), PP2 (c-SRC) inhibitor, 
Wortmannin (PI3K) inhibitor, Pertussis toxin PTX (G protein) inhibitor, Y27632 (ROCK2) 
inhibitor for one hour before adding G1 for 30mins.  
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Figure 4. Rapid activation of GPER is linked to breast cancer cell cytoskeletal and cell 
membrane rearrangement 
Actin stress fibers in ER negative MDA MB468 breast cancer at baseline were arranged 
longitudinally in the cytoplasm and the cell membrane was regular. Activation of GPER with G1 
and E2 (1 µM) resulted in a rapid shift of the actin fibers toward the edge of the membrane, 
whereas G1 and E2 failed to induce actin remodeling to the cell membrane in the cells transfected 
with GPER shRNA plasmid. (Fig. 2A). 
 
Figure. 4. Immunofluoresence. E2and G1 induces actin cytoskeleton remodeling. MDA MB 468 
cells were transfected with shRNA GFP GPER for 48 hours in cover slips and then the cells were 
treated with G1 and E2 for 30mins at 1uM concentration. Cells were stained with Texas Red 
conjugated with phalloidin and counterstained with DAPI. 
Control and GPER control 
G1shRNA GPER + G1 control 
E2shRNA GPER + E2 control 
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Figure 5. E2 drives breast cancer cell invasion. 
In the inserts with GFR MatrigelTM, recruitment of GPER with G1 or E2 promoted invasion of the 
matrix by cancer cells (Fig. 1B). The number of cells that invaded the matrix in the presence of E2 
and G1 was higher than non treated cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure.5. Invasion assay. MDA MB 468 Cells were treated for 24 hours with G15 (GPER 
antagonist) and G1 and E2and then the cells were stained with toluidine blue.  
E2 
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DISCUSSION 
My second part of the thesis identifies the activation of Moesin and FAK phosphorylation by 17β 
E2 and G1 in MDA MB468 breast cancer cell which is exerted through rapid non genomic 
signaling to the various signaling intermediates.  
Activation of Moesin and FAK phosphorylation and actin cytoskeleton remodeling by estrogens 
has been reported previously in our lab (Giretti MS and Xiao dong fuet al), normally estrogens 
activate rapid and non rapid signaling pathways through its endogenous estrogen receptors 
however it is not known how estrogens mediate this effects in the absence of estrogen receptors.  
Previous studies identified trans-membrane G protein-coupled estrogen receptor 1 (GPER, GPR30) 
has been implicated in rapid non-genomic effects of estrogens. Estrogen activation of GPER 
increased adenyl  cyclase activity in ER negative, GPER positive breast cancer cells (Filardo, 
2002; Filardo et al., 2000). This gave us an idea to test whether estrogen uses GPER in ER 
negative breast cancer cells. 
We here show that estrogen induces actin remodeling and invasion of three-dimensional matrices 
of ER- breast cancer cells by phosphorylating the actin-binding proteins, Moesin and FAK. Moesin 
resides at the nexus of multiple pathways regulating cell attachment with the extracellular matrix 
and with nearby cells, cell motility and metastatic potential as well as cell survival. These 
functions are directed by Moesin and FAK though the modulation of actin cytoskeleton/plasma 
membrane interactions. 
We here extend this concept showing that estrogen drives GPER to activate actin cytoskeleton 
remodeling and invasion in MDA MB 468 breast cancer cell through various signaling 
intermediates. Our previous work in ER positive T47D breast cancer cells shows that 
GPER/PI3K/c-Src/RhoA/ROCK/Moesin and FAK cascade is necessary for the cytoskeletal 
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remodeling and for the enhancement of breast cancer cell horizontal migration and invasion of 
three-dimensional matrices induced by estrogen (Giretti MS et al., 2007).We tested whether the 
same signaling pathways estrogens uses in MDA MB468 breast cancer cells. Interestingly the 
pathways used by E2 in ER positive T47D cells also used same pathway in ER- MDA breast 
cancer cells. In fact, the specific GPER antagonist G-15 inhibits estrogen activated Moesin and 
FAK phosphorylation and such stimulation was further augmented by the specific GPER agonist 
G-1.  
In conclusion, the present results suggest that within the broader range of actions of estrogen 
receptors, the rapid extra-nuclear signaling to the actin cytoskeleton through the GPER/PI3K/c-
SRC/RhoA/ROCK/Moesin/FAK cascade is relevant for the determination of estrogen receptor 
negative breast cancer cell movement and invasion that are related to cancer metastasis. This is a 
preliminary work to show the actions of Estrogens in ER- breast cancers. Further work needs to be 
done to support the notion the full mechanistic basis of cell movement and invasion in ER- and 
ER+ breast cancers. Interestingly, in ER+ GPER+ breast cancer cells, function of E2 is abolished 
when ER is knockdown using siRNA against ER hence it would be very interesting to study why 
E2 does not activate several rapid non genomic intermediates in ER knock down GPER positive 
breast cancer cells. The characterization of these actions increase our understanding of the effects 
of estrogens on breast cancer progression and might be useful to develop new tools to interfere 
with the ability to diffuse locally or at distant sites of ER− breast carcinomas and the discovery of 
the new membrane bound estrogen receptor GPER may allow understanding of the previously 
reported non-genomic membrane effects of estrogen. 
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CONCLUSIONS 
In conclusion, this thesis shows that there are a number of emerging and yet poorly characterized 
actions of conventional and non-conventional estrogen receptors that control cell cytoskeleton 
architecture and cell motility. These actions apply to cell types such as endothelial and breast 
cancer cells. Through the activation of these mechanisms of action estrogens and other ligand for 
these receptors may contribute to physiological phenomena such as angiogenesis, vascular 
remodeling and cancer progression. The further understanding of this novel way of cell regulation 
by steroid receptors may open new approaches based on the engineering of selective agonists and 
antagonists of these receptors, which could be useful in cardiovascular disease and cancer. 
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